Effect of 1 alpha-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231.

scientific article published on July 1984

Effect of 1 alpha-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/BJC.1984.148
P932PMC publication ID1976920
P698PubMed publication ID6743510
P5875ResearchGate publication ID241604110

P2093author name stringT Sato
K Konno
K Takusagawa
N Asoo
P2860cites workDifferentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3Q35462970
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cellsQ37600754
Specific binding of 1alpha,25-dihydroxycholecalciferol to nuclear components of chick intestineQ39918477
Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in cultureQ52828892
Antitumor effect of 1 alpha-hydroxyvitamin D3.Q54660359
Metabolism of 1α-hydroxyvitamin D3 to 1α,25-dihydroxyvitamin D3 in perfused rat liverQ67320995
1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in cultureQ72878839
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)123-125
P577publication date1984-07-01
P1433published inBritish Journal of CancerQ326309
P1476titleEffect of 1 alpha-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231.
P478volume50

Reverse relations

cites work (P2860)
Q414690011 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro
Q781712121alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma
Q61023219Calcitriol and cancer therapy: A missed opportunity
Q73670882Induction of differentiation by 1alpha-hydroxyvitamin D(5) in T47D human breast cancer cells and its interaction with vitamin D receptors
Q44637210Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies.
Q37695300The future of vitamin D analogs
Q37936093Vitamin D in oncology
Q41441793Vitamin D influences gap junctional communication in C3H/10T 1/2 murine fibroblast cells

Search more.